Want to see HK:1863 full AI Analyst Report?
1863 Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
Bulls Say, Bears Say
Bulls Say
Sustained ProfitabilityThe company remains profitable despite recent pressure, providing a durable earnings base to fund operations and strategic reinvestment. Persistent profitability supports debt servicing and operational continuity, giving management time to address margin and cash conversion issues.
Strengthened Equity BaseReported growth in equity and a non-distressed balance sheet create a structural capital cushion. A larger equity base improves long-term solvency, supports absorbtion of cyclical shocks, and increases capacity to raise capital for strategic initiatives if needed.
Underlying Revenue GrowthModest revenue growth (~3.45%) signals enduring demand resilience versus sharper cyclicality. Over a multi-quarter horizon, steady top-line expansion—if maintained—can enable scale economies, gradual margin recovery, and a more predictable cash-flow profile.
Bears Say
Rising LeverageLeverage rising materially to ~0.9 reduces financial flexibility and raises refinancing and interest-rate exposure. Higher debt amplifies earnings volatility and restricts funding for capex or M&A, making the company more sensitive to profit shortfalls and macro shocks.
Inconsistent Cash GenerationHighly volatile and frequently negative free cash flow undermines the company's ability to self-fund investments, debt service, and shareholder returns. Persistent cash conversion weakness forces reliance on external financing and increases operational risk over the medium term.
Margin And Profit CompressionSustained compression of gross and operating margins reduces return on invested capital and weakens the capacity to rebuild balance-sheet strength. If cost pressures or weaker pricing persist, lower profitability will further constrain reinvestment and elevate financial risk.
China Longevity Group Co. Ltd. News
1863 FAQ
What was China Longevity Group Co. Ltd.’s price range in the past 12 months?
Currently, no data Available
What is China Longevity Group Co. Ltd.’s market cap?
Currently, no data Available
When is China Longevity Group Co. Ltd.’s upcoming earnings report date?
China Longevity Group Co. Ltd.’s upcoming earnings report date is Sep 02, 2026 which is in 27 days.
How were China Longevity Group Co. Ltd.’s earnings last quarter?
China Longevity Group Co. Ltd. released its earnings results on Mar 27, 2026. The company reported HK$0.035 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.035.
Is China Longevity Group Co. Ltd. overvalued?
According to Wall Street analysts China Longevity Group Co. Ltd.’s price is currently Overvalued.
Does China Longevity Group Co. Ltd. pay dividends?
China Longevity Group Co. Ltd. pays a Annually dividend of HK$0.1 which represents an annual dividend yield of N/A. See more information on China Longevity Group Co. Ltd. dividends here
What is China Longevity Group Co. Ltd.’s EPS estimate?
China Longevity Group Co. Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does China Longevity Group Co. Ltd. have?
China Longevity Group Co. Ltd. has 852,612,500 shares outstanding.
What happened to China Longevity Group Co. Ltd.’s price movement after its last earnings report?
China Longevity Group Co. Ltd. reported an EPS of HK$0.035 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of China Longevity Group Co. Ltd.?
Currently, no hedge funds are holding shares in HK:1863
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
China Longevity Group Co. Ltd.
China Longevity Group operates within the reinforced materials industry, engaging comprehensively in the design, development, production, and distribution of its specialized products. These offerings include advanced polymer-processed polyester fabric composite materials, diverse reinforced composites, conventional materials, and a range of inflatable and waterproof items. The company's versatile products find widespread application across numerous sectors, such as outdoor recreation, sports, renewable energy, protective equipment, construction, transportation, packaging, medical uses, safety solutions, advertising, and everyday consumer goods. Its commercial reach extends globally, with a notable presence in China, the USA, Russia, and various other international markets.
Perfect Medical Health Management Limited
―
EC Healthcare
―
Hospital Corporation of China Ltd
―
Town Health International Medical Group Ltd.
―
UMP Healthcare Holdings Limited
―